Panday, Khryss Ann T.
HRN: 15-66-70 Sex: FemalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
04/18/2025
CEFUROXIME 1.5GM (VIAL)
04/18/2025
04/19/2025
IV
1.5 G
Loading Dose
For Stat CS For NRFS
Waiting Final Action
Indication: Prophylaxis Type of Infection: Reproductive Tract Compliance to guidelines: Compliant To Guidelines
Initial appropriateness: Yes
Final appropriateness: Yes
Overall appropriateness: Yes